识别一个关键的功能域和改进的PHOX2B误解变体解释,利用in-silico预测工具
Andy Drackley1,2,3, Andrew D Skol1,4, Casey M Rand4,5
1Department of Pathology & Laboratory Medicine, Molecular Diagnostics Laboratory, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA, luriechildrens.org.
Human mutation
|March 11, 2026
概括
对先天性中央低通风综合征 (CCHS) 的PHOX2B误解变体进行解释是具有挑战性的. 这项研究确定BayesDel和REVEL是卓越的预测工具,提高了CCHS患者的诊断准确性.
科学领域:
- 遗传学 是一个遗传学.
- 生物信息学是一种生物信息学.
- 临床遗传学 临床遗传学
背景情况:
- 在PHOX2B的致病性异构体变体导致先天性中央低通风综合征 (CCHS),一种影响呼吸控制的疾病.
- 由于稀有性和有限的功能数据,解释PHOX2B误解变体是很困难的,导致许多意义不明的变体 (VUS).
研究的目的:
- 开发一个改进的模型来评估PHOX2B误解变体.
- 评估和校准用于PHOX2B变种分类的in silico致病性预测工具.
- 在PHOX2B.中识别关键的功能域.
主要方法:
- 从文献和数据库中收集了PHOX2B误解变体.
- 使用CADD,REVEL,BayesDel和AlphaMissense获得的致病性预测得分.
- 应用加权后勤回归来评估ACMG/AMP指南PP3/BP4标准的证据.
- 分析变体的位置分布,以确定热点.
主要成果:
- 对于PP3/BP4标准来说,CADD,REVEL和BayesDel的预测能力已经得到证明.
- 贝叶斯Del和REVEL被确定为PHOX2B误解变异的最强的预测工具.
- 发现致病变体聚集在PHOX2B主体内,支持该地区的PM1标准.
结论:
- 校准的计算工具 (BayesDel,REVEL) 提高了PHOX2B误解变异分类的准确性.
- 减少VUS分类将改善CCHS的及时诊断和临床管理.
- 识别家庭主体作为一种病原性变异热点有助于变异解释.
关键词:
阿尔法Missense的意思是错误的贝耶斯德尔 (BayesDel) 是一个城市.这就是为什么CADD是CADD.CCHS CCHS 在线阅读这就是PHOX2B.这是Revel的启示.生产中的中央低通风综合征.家庭 家庭领域 家庭领域在Silico预测中的预测变体解释变体解释更多相关视频
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
10.6K
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
1.7K
相关概念视频
Point and Frameshift Mutations
1.5K
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.5K
Pharmacogenomics: Identification of New Drug Targets
59
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
59
